Seznam všech zadavatelů
Zobrazuji zprávy zadavatele: Debiopharm International SA
Nalezený počet: 5
DEBIOPHARM ANNOUNCES LAUNCH OF THE PHASE 1/2 GaLuCiTM STUDY FOR ITS CA IX-TARGETED RADIOPHARMACEUTICAL PROGRAM
Lausanne (Switzerland) March 22nd 2023 (PROTEXT/ots) - - Debiopharm is developing personalized radiotherapy through a theranostic approach, combining diagnostic imaging (Debio 0328 a gallium-labelled imaging tool) and therapeutic components (Debio 0228,...
Zadavatel: Debiopharm International SA
DEBIOPHARM EXTENDS THEIR DNA DAMAGE REPAIR FOOTPRINT WITH NEW ONCOLOGY PIPELINE ENTRY
Lausanne (Switzerland) March 2nd 2023(PROTEXT/ots) - Debiopharm obtains global rights from Novo Nordisk for the development of their ubiquitin-specific protease 1 (USP1) inhibitor Debiopharm (www.debiopharm.com), an independent Swiss-based, biopharmaceutical...
Zadavatel: Debiopharm International SA
Debiopharm Co-leads a 10M USD Series A Round to Accelerate the Development of Genomic Medicines through Artificial Intelligence
Lausanne September 13th 2022 (PROTEXT/ots) - Debiopharm Innovation Fund strategically invests in Whitelab Genomics' mission to make genomic medicine development faster and leaner for more efficient access to cancer patients in the future Debiopharm...
Zadavatel: Debiopharm International SA
Series A financing round lays foundation for international growth of digital cancer therapeutics Mika
Berlin/Lausanne/Barcelona/Munich May 9th 2022 (PROTEXT/ots) - New investors with a successful track record in digital oncology support German Digital Therapeutics (DTx) company Fosanis to broaden patient access of Mika – an app-based DTx platform empowering...
Zadavatel: Debiopharm International SA
CARB-X FUNDS THE 3RD ROUND OF DEBIOPHARM’S TARGETED ANTIBIOTIC PROGRAM TO COMBAT RESISTANT N. GONORRHOEAE INFECTIONS
Lausanne (Switzerland)/ Boston (USA) October 19th 2021 (PROTEXT/ots) - Debiopharm, a Swiss-based global biopharmaceutical company announced today having been awarded the third phase funding to advance the development of its antibiotic program, Debio 1453,...
Zadavatel: Debiopharm International SA
Vaše tiskové zprávy rozšíříme spolu se zpravodajstvím ČTK uživatelům agenturního servisu jako jsou média, ekonomická sféra, státní správa a veřejnost. Texty zůstávají uloženy v Infobance ČTK, jsou součástí mobilní aplikace ČTK a obdrží je také tisíce odběratelů našeho e-mail servisu. Veřejnosti je zpřístupníme na více než 15 zpravodajských portálech.
Doporučujeme
Slavnostní vyhlášení prestižní soutěže Czech Press Photo 2026